Concerns about high-cost drugs have not gone unnoticed at the Department of Health and Human Services, and HHS will take an opportunity to learn more about the issues by holding a public forum Nov. 20.
The agenda for what is being called "HHS Pharmaceutical Forum: Innovation, Affordability and Better Health" appears primarily focused on gaining...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?